Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14+R) in high-risk diffuse large cell lymphoma

Medical Oncology

Volumn 24, Issue 1, 2007, Pages 85-89

  Avilés, Agustin ^a,b   Nambo, María J ^a   Neri, Natividad ^a   Cleto, Sergio ^a   Castañeda, Claudia ^a   Huerta Guzmàn, Judith ^a   Murillo, Edgar ^a   Contreras, Margarita ^a   Talavera, Alejandra ^a   González, Martha ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b NONE   (Mexico)

Author keywords

Diffuse large cell lymphoma; Malignant lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FILGASTRIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; CEOP PROTOCOL 1; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HUMAN; INJECTION SITE REACTION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; AGED; DOSE RESPONSE; MIDDLE AGED;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 34548743928     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02685907     Document Type: Article

References (22)

1. The International Non-Hodgkin's Lymphoma Prognostic Factors Project 1993 A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 987 994
2. MA Shipp 1995 High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma J Clin Oncol 13 916 923
3. NL Bartlett 2001 Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone and etoposide (CHOPE) chemotherapy for patients with diffuse large cell lymphoma Cancer 92 207 217
4. B Coiffier 2005 State of the art therapeutics. Diffuse large cell lymphoma J Clin Oncol 23 6387 6393
5. DW Blayney 2003 Dose-intense chemotherapy every 2 weeks with dose intense cyclophosphamide, doxorubicin, vincristine and prednisone may improve survival in intermediate- and high grade lymphoma J Clin Oncol 21 2966 2973
6. K Itoh 2002 Randomizded phase II study of bi-weekly CHOP and dose-escalation with prophylactic use of Lenogastrin (glycosilated G-CSF) in aggressive non-Hodhkin's lymphoma Ann Oncol 13 1347 1355
7. M Pfreundschun 2004 Two-weeks or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas Blood 104 626 633
8. M Balzarotti 2002 Intensified CHOP regimen in aggressive lymphoma. Maximal dose intensity and dose density of doxorubicin and cyclophosphamide Ann Oncol 13 1341 1346
9. CS Portlock 2004 The NHL-15 protocol for aggressive non-Hodgkin's lymphoma. A sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide Ann Oncol 15 1495 1503
10. DW Blayney BW Mcguirre SE Cruickshank DH Johnson 2005 Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma The Oncologist 10 138 149
11. HC Kluin-Nelemans 2001 Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma J Natl Cancer Inst 93 22 30
12. J Strehl 2003 High-dose chemotherapy followed by stem cell transplantation a first line therapy in aggressive non-Hodgkin's lymphoma. A Meta-analysis Haematologica 88 1304 1315
13. AP Lauchbuny N Habboubi 1993 Epirubicin and doxorubicin. A comparison of their characteristics, activity and toxicity Cancer Treat Rev 19 197 228
14. A Avilés 2004 Intensive chemotherapy in the treatment of aggressive diffuse large cell lymphoma Med Oncol 21 269 272
15. A Avilés 2004 Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improve outcome Leuk Lymphoma 45 1385 1389
16. BD Cheson 1999 Report of a International Workshop to standardize response criteria for non-Hodgkin's lymphoma J Clin Oncol 17 1244 1251
17. RI Fisher 1993 Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma N Engl J Med 328 1002 1006
18. KS Zuckerman DC Case Jr RA Gams ER Prasthofer 1993 Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphoma with an intensive epirubicin-containing regimen Blood 82 3564 3573
19. A Avilés A Calva JC Díaz-Maqueo A Talavera J Huerta-Guzmán E Vásquez 1997 Dose escalating of epirubicin in the CEOP-Bleo regimen Leuk Lymphoma 25 319 325
20. F Rossini 2004 Long-term follow-up of patients with intermediate- and high-grade non-Hodgkin's lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone Cancer 100 350 356
21. JM Vose 2001 Phase II study of rituximab in combination with CHOP chemotherapy in patients previously untreated aggressive non-Hodgkin's lymphoma J Clin Oncol 19 389 397
22. Glass B, Kloess M, Engert W, Berdec B, Metzner L. Dose escalated CHOP + etoposide and repetitive autologous stem cell transplangtation (MegaCHOEP) with and without rituximab for primary treatment of aggressive NHL. Proc Assoc Clin Oncol 2005;23, 598s (Abstract 6654).